Sunday, April 15, 2018

NEW YORK (Reuters) - Mylan N.V.'s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment's manufacturer said on Friday.


from Reuters: Health News https://ift.tt/2GWjZho

Related Posts:

  • LATEST HEALTH NEWSJPMorgan Chase & Co said on Monday its head of community and consumer banking Gordon Smith will attend a meeting at the White House on Wednesday to discuss the economic impact of the fast-spreading coronavirus. from … Read More
  • LATEST HEALTH NEWSThe whole of Italy will be placed under lockdown until next month, Prime Minister Giuseppe Conte announced on Monday, in an unprecedented and unexpected new attempt to beat coronavirus in Europe's worst-affected country. … Read More
  • LATEST HEALTH NEWSKuwait suspended on Saturday all flights to and from Egypt, Lebanon, Syria, Bangladesh, Philippines, India, and Sri-Lanka for a week starting on Saturday, Kuwait's civil aviation directorate said in a tweet. from Reuters… Read More
  • LATEST HEALTH NEWS(Reuters Health) - A cheaper HIV prevention pill is going on sale soon in the U.S., but the price drop won't help as many people if doctors instead prescribe a newer, more expensive brand-name drug, experts say. from Reu… Read More
  • LATEST HEALTH NEWSThe number of people infected with the coronavirus topped 111,000 across the world as the outbreak spread to more countries, causing greater economic damage. from Reuters: Health News https://ift.tt/2W2Cjf5 … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner